Trials / Completed
CompletedNCT02691741
Clinical Investigation of Visual Function After Bilateral Implantation of Two Presbyopia-Correcting Trifocal Intraocular Lenses (IOL)
Clinical Investigation of Visual Function After Bilateral Implantation of Two Presbyopia-Correcting Trifocal IOLs
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 215 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 22 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to clinically evaluate the visual performance of two commercially available presbyopia-correcting Trifocal IOLs.
Detailed description
Subjects will attend a total of 9 visits (6 postoperative) over a 7 month period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | AcrySof® IQ PanOptix™ Presbyopia-Correcting IOL | Trifocal IOL(near, intermediate, distance) implanted for long-term use over the lifetime of the cataract patient |
| DEVICE | AT LISA® tri IOL | Trifocal IOL(near, intermediate, distance) implanted for long-term use over the lifetime of the cataract patient |
Timeline
- Start date
- 2016-04-29
- Primary completion
- 2017-07-17
- Completion
- 2017-07-17
- First posted
- 2016-02-25
- Last updated
- 2019-09-27
- Results posted
- 2019-09-27
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02691741. Inclusion in this directory is not an endorsement.